ABSTRACT -Context -Hepatic fibrosis occurs in response to several aggressive agents and is a predisposing factor in cirrhosis.
INTRODUCTION
Hepatic fibrosis results from a shift in the constant balance between aggressive and regenerative processes, in which the primary characteristic is morphological alteration of the hepatic parenchyma (14, 25) . Fibrosis is an essential component in the development of cirrhosis, characterized by the presence of regeneration nodules that form irregular islets of hepatocytes surrounded by scarred connective tissue (27, 39, 43) . The final consequence of cirrhosis is the impairment of liver function (18, 28, 34, 38) . Several clinical and surgical treatments have been proposed to reduce fibrosis and cirrhosis (13, 19, 34, 36, 37) . Modification of the disturbed histology in fibrotic livers by stimulation of regenerative processes, such as partial hepatectomy, has been proposed (17) . However, this can increase the functional deficit of an already failing organ (3, 4, 42) . Currently, the only definitive treatment when fibrosis progresses to advanced cirrhosis is liver transplant; but this procedure has several technical and physiological limitations (5, 8, 9, 11, 26) .
A different approach to stimulate hepatic tissue and improve the quality of liver recovery is the use of exogenous hepatotrophic factors (10, 19, 35, 44) . Parra et al. (31, 32, 33) developed an experimental model in rats based on administration of hepatotrophic factors (HF) solution. They can influence the growth, trophism, and histological architecture of the liver, and this solution consist of several amino acids, vitamins, glucose, insulin, glucagon, and triiodothyronine (T 3 ). Administration of HF into the portal circulation of healthy rats promoted growth of additional liver mass, with an increase from 34.5 to 149% (31, 32) and a decrease of 37.5% in the volumetric density of collagen fibers (33) . These results raised the possibility of using hepatotrophic substances to directly stimulate liver regeneration in patients with fibrosis, thus improving liver function and reducing or reversing fibrosis.
The aims of this study were to test the effects of HF solution developed by Parra et al. (31, 32, 33) on liver fibrosis in rats. This therapy promotes a decrease of collagen content in liver parenchyma, as well as improvements in liver histopathology and the blood hepatic-lesion markers.
METHODS

Animal protocols and induction of fibrosis
Seventy 2-month-old female Wistar rats weighing 220 ± 10 g were used in this study. They were fed with a standard rat diet and water ad libitum and housed in cages with controlled temperature and humidity. The rats were provided by the animal facility of the Department of Pathology, School of Veterinary Medicine, University of São Paulo, SP, Brazil. All rats were cared for according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals (21) ; the experimental procedure was approved by Bioethics Committee of our institution (protocol n o . 63/02). Fibrosis was induced by gastric gavage with an aqueous solution (10 mg/kg) of dimethylnitrosamine (DMN, Sigma-Aldrich, St Louis, Missouri, USA) twice a week for 5 weeks, followed by a resting period of 4 weeks. The mortality rate during the 9 weeks of treatment was 10%. After, the rats were anesthetized with isoflurane and a biopsy sample was surgically collected for histopathological analysis before treatment. All rats survived biopsy and subsequent treatments until the end of the experiment.
Treatment with hepatotrophic factors and saline solution
Fifteen days after the biopsies, rats (n = 30) in the HF group received intraperitoneal injections of HF solution (40 mg/kg/ day), as described by Parra et al. (31, 32, 33) , divided into two daily doses for 10 days. The HF solution is composed by: glucose (104 g), amino acids solution (200 mL), pyridoxine (2 mg), calcium pantothenate (2 mg), thiamine (30 mg), riboflavin phosphate (4 mg), potassium chloride (1.43 g), sodium bicarbonate (1.5 g), nicotinamide (50 mg), monopotassium phosphate (750 mg), magnesium sulfate (500 mg), vitamin C (500 mg), insulin (62.5 IU), glucagon (0.625 mg), folic acid (2. 
Biometrics, necropsy, and histopathology
The animals were weighed and euthanized in a CO 2 chamber. Live body weight (LBW), carcass weight (CW, body weight of the animal eviscerated), and liver weight (LW) were Fragments from each liver were fixed in bouin fixative for 12 h, embedded in paraffin wax, and 5-mm tissue sections were stained with hematoxylin-eosin, picrosirius-hematoxylin, and picrosirius alone (22) . Histological sections obtained from biopsies of each rat were compared with histological sections from necropsy samples from the same rat after treatment. Ten animals from each group were analyzed for the following lesions: regenerative nodules, fibrosis and fibrotic bridges, inflammatory infiltrate with oval cells, proliferation of bile ducts, and megalocytosis. The intensity of each lesion was classified as light (1 point), moderate (2 points), or severe (3 points).
Serum biochemistry analysis
Blood samples from all animals were obtained by cardiac puncture just before euthanasia. Serum albumin (bromocresol green method), total protein (biuret method), AST and ALT enzyme activity (Biosystems  kits, BioSystems S.A, Barcelona, Spain) were analyzed on a BST-379 plus Automatic Analyzer. A group of 30 healthy reference rats was also studied (R group) in order to obtain reference values for the experiment.
Collagen morphometry
Morphometric analysis of collagen was carried out on samples obtained from 10 rats from each group. The volumetric density of perisinusoidal collagen fibers in liver parenchyma was calculated using Kontron Zeiss morphometry software KS 400.3 (Carl Zeiss Vision GmbH, Halldergmoos, Germany). Briefly, the total microscopic-field area of a picrosirius-stained section was measured with a 100× objective. The images were captured in black and white with a green filter in order to increase the contrast of the red collagen fibers. In the same field, the fibers were separated from the background by a threshold macro and the area of the collagen fibers was determined. This procedure was repeated 10 times on different areas of the same histological section. The areas of all 10 fields from each section were summed, as were the collagen areas from each field. The proportion of collagen relative to the field area in one section was calculated. The procedure was repeated on 10 histological non-serial slides for each rat, and the mean and standard deviation were determined. The resulting average proportion of area occupied by collagen in the liver parenchyma of each rat is considered an accurate estimate of the collagen volumetric density in the parenchyma (1, 41) . In the next step, the collagen around the perivascular spaces (portal space and central veins) was quantified. However, the size of the target vessels was variable and the quantity of surrounding collagen may have reflected this variability. Thus, in order to normalize the amount of collagen in perivascular spaces, the collagen area measured around each blood vessel was related to the blood vessel area (portal vein in the portal space or the central vein). Pearson's correlation coefficient was used to measure the linearity of the relationship between the variables collagen area and vessel lumen area. 
Statistical analysis
Different comparison tests were performed between experimental groups. Analysis of variance (Levene test) and Student's t test was used to test differences between means. The Wilcoxon matched-pairs signed-ranks test was used to intragroup (biopsy and treatment) comparisons. A 1-way analysis of variance (ANOVA) test with Tukey post-test was used to analyze differences among the means. Pearson's coefficient of correlation was carried out between collagen area and area of the blood vessel lumen means. The results were expressed as mean ± SD. The Minitab 15 statistical software was used, and a P value less than .05 was considered significant.
RESULTS
Biometry and histopathology
The LW, HSI, and HCI increased by 15.5%, 14.2%, and 21.6%, respectively, in the HF group compared to the S group (Table 1) . Histopathology examination of biopsies obtained before treatment showed the presence of hepatic fibrosis with diffuse regenerative nodules, irregularly disseminated, bridges of fibrous connective tissue surrounding the nodules, and accentuated periportal fibrosis ( Figure 1A-C) . A multifocal inflammatory infiltrate was also observed, especially in the portal space, with oval cells, proliferation of bile ducts, and megalocytosis of hepatocytes. There were no neoplasic lesions in animals of both groups. Comparison of the paired biopsy and S liver samples showed a 27% reduction of periportal fibrosis, a 20% reduction of inflammatory infiltrate with oval cells, and a 15% reduction of bile-duct proliferation 5 weeks after interruption of DMN treatment. In the livers of rats treated with HF, the reduction of periportal fibrosis and fibrotic bridges (60%), inflammatory infiltrate with oval cells (36%), and bile-duct proliferation (36%) was much greater than in the biopsies previously obtained from each animal ( Figure 1D , Table 2 ). Regenerative nodules were observed in biopsy samples, but disappeared in the HF group after treatment ( Figures 1D, 2C) . Data are mean ± SD (S group, n = 15; HF group, n = 30). Student's t-test was used to test for differences between means. LBW = live body weight at euthanasia; LW = liver weight; HSI = hepatosomatic index; HCI = hepatocarcass index Serum biochemistry analysis and collagen morphometry Serum albumin and total protein concentrations increased 23.6% and 14.7%, respectively, in HF-treated animals. Serum AST and ALT activities were reduced 36 and 49.2% in rats from the HF group (Table 3 ). All comparisons of collagen morphometry were done in paired The intensity of each lesion was ranked as light =1, moderate =2, or severe = 3. Data are mean ± SD (n = 10). The Wilcoxon matched-pairs signed-ranks test was used to for intragroup (biopsy and treatment) comparisons (Table 4 ). The IPCs measured around the central vein and portal spaces were also reduced (31.6% and 57.7%, respectively) after HF treatment. By contrast, rats in the S group showed a 42.7% increase in the IPC from around the central vein (Table 4) , while the other areas showed no significant differences (P>.05) compared with those from the biopsies (Figure 1 ).
DISCUSSION
The rationale behind the use of liver-trophic substances is the assumption that liver size is regulated by the amount of blood arriving through the portal vein and by Data are mean ± SD. Numbers in parentheses are Pearson's coefficient of correlation. Student's t-test was used to test differences between means. (n = 10). R = Correlation coefficient between collagen area and area of the blood vessel lumen; VD = collagen-fiber volumetric densities in perisinusoidal spaces; IPC = index of perivascular collagen the concentration of portal-blood components, as was suggested to explain liver growth in small-for-size liver transplants (12, 20, 23, 40) . An opposite effect is observed when the concentration of portal blood components is reduced by malnutrition, in which there is a marked decrease in the size of the liver (32) . Thus, increasing the concentration of hepatotrophic substances in the portal blood, such as by intraperitoneal administration of HF, is expected to result in liver enlargement. In our experiment, liver size indeed increased, confirming that hepatic growth can be modulated in fibrotic livers by the factors contained in the HF solution. In previous work, the total DNA content of healthy rat livers treated with HF increased by 60%, strongly suggesting that HF stimulates cell proliferation and that the liver grew through hyperplasia (32) . Parra et al. (31, 32, 33) found that intraperitoneal administration of HF to healthy rats for 10 days promoted liver growth, with an increase in liver mass ranging from 34.5% to 149%. The same protocol was followed in treating animals with DMN-induced fibrosis and resulted in a 17.2% increase in liver mass. The effect was therefore less intense than observed in healthy livers. The fibrotic process causes a narrowing of the sinusoidal spaces and, consequently, impairs the exchange of nutrients between the blood and hepatocytes, which may account for the reduction of HF efficacy in the fibrotic liver (16, 24) . Fibrosis is a predisposing component in the development of cirrhosis (25, 27, 39) , and different patterns of fibrosis are produced in response to injury. Liver biopsies showed microscopic lesions consistent with fibrosis, which indicated that extensive lesion formation was induced by the hepatotoxic action of DMN (2) . Bile-duct proliferation is a characteristic lesion that represents a functional deficit. The presence of an inflammatory process, with oval cells and hepatocyte megalocytosis, is pathognomonic for an immunological response to cellular injury (15, 31) . Animals from the HF group showed an improvement in this histopathological picture compared with the S group, indicating that treatment accelerated the recuperation of the liver parenchyma. The absence of neoplasic lesions indicated that the HF solution has no carcinogenic potential in rats with chronic hepatic disease.
The administration of HF to rats with hepatic fibrosis also promoted superior recovery of the liver microscopic architecture, stopping and reverting the fibrotic process. This was shown by the impressive reduction of the collagen volumetric density in the liver parenchyma of rats in the HF group. There was a larger reduction of the collagen content in the portal space than in the central vein region in HF-treated rats. This was most likely resulted from the influx of a richer and more nutritious blood flow at the periportal region, due to its more favorable anatomical position.
The serum aminotransferases ALT and AST are reliable indicators of functional or structural alterations of hepatic cells, and can be useful in the diagnosis of hepatic diseases (29, 30) . The serum levels of these enzymes in the HF group returned to the values measured in rats of the reference group. The hepatocytes of HF-treated rats may thus have recovered their cellular integrity to a greater extent than those in the S group. In the latter, serum AST and ALT activities were higher than in the reference group. The persistently high levels of these enzymes indicated that hepatocellular lesions were still present 5 weeks after DMN treatment was interrupted. A similar, accentuated increase of these enzymes was noted in rats intoxicated by carbon tetrachloride (6) . In hepatic fibrosis, hepatocellular protein secretion is reduced due to the loss of fenestrations on sinusoidal endothelial cells through continuous collagen deposition in perisinusoidal spaces (7) . Rats from the HF group had higher serum albumin and total protein concentration values than rats from the S group, suggesting greater hepatic secretion and reflecting the beneficial action of the HF solution on liver-cell function. It is possible that the HF-induced reduction of collagen-fiber deposition in perisinusoidal spaces allowed hepatic cells to gain easier access to blood and nutritional factors and improved secretion of cellular metabolic products (19, 24, 34) . Serum concentrations of aminotransferases and total protein were similar in rats from the HF group and the reference group.
The ability of HF to reduce the collagen content of fibrotic liver parenchyma, as demonstrated here, may have been the result of liver growth, which is associated with reorganization of the parenchymal architecture and, necessarily, with collagen rearrangement. A similar effect occurs during cell division after partial hepatectomy and results in both a loss of the liver typical histological architecture and a 50% reduction of the volumetric density of collagen (33) . We therefore postulate that the growing process triggered by HF stimulates a restructuring of the hepatic framework through the reabsorption and new synthesis of collagen. The removal of excess collagen around sinusoids and other vessels probably creates easier access by hepatocytes to the blood environment, which was enriched by the high concentration of HF. In turn, this promoted faster recovery of the liver from the DMN-induced lesions. Taken together, these results suggest the potential therapeutic use of HF solution to treat chronic liver diseases.
